Jane Street’s Nuvectis Pharma NVCT Stock Holding History

Jane Street’s Portfolio NVCT Stock Details NVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Buy	+15,582	New	+$174K	﹤0.01%	9310
2025 Q4	–	Sell	-26,278	Closed	-$171K	–	11978
2025 Q3	$158K	Buy	+26,278	New	+$181K	﹤0.01%	9849
2025 Q2	–	Sell	-42,299	Closed	-$413K	–	10479
2025 Q1	$413K	Buy	+42,299	New	+$305K	﹤0.01%	7220
2024 Q3	–	Sell	-17,021	Closed	-$108K	–	10146
2024 Q2	$108K	Buy	+17,021	New	+$116K	﹤0.01%	8700
2023 Q2	–	Sell	-11,086	Closed	-$145K	–	9291
2023 Q1	$145K	Buy	+11,086	New	+$112K	﹤0.01%	8030

Other funds holding NVCT

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Jane Street's NVCT Position: Q2 2026 in Review

Jane Street opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 15,582 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #9310 among its holdings. This is a return to the name: Jane Street previously reported a position in NVCT as recently as Q3 2025.

Jane Street first reported a position in NVCT in Q1 2023 and has held it in 5 quarters since. The position peaked at $413K in Q1 2025. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

Jane Street held 15,582 shares of Nuvectis Pharma worth $287K as of Q2 2026.
Nuvectis Pharma was a new Jane Street position in Q2 2026.
Nuvectis Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9310 holding.
Jane Street first reported a position in Nuvectis Pharma in Q1 2023 and has held it in 5 quarters since.
Jane Street's Nuvectis Pharma position peaked at $413K in Q1 2025.
83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.